Delivery Order SPE2DB20D3103-SPE2DB25FP4Y7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,155.97 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.23 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitively awarded, firm fixed price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,379.83 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 23, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,817.31 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine medical supply procurement under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,824.58 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12 gram units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,503.91 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This is a firm fixed price, non-set-aside contract with a completion date of March 20, 2025, just one day after the award date of March 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,189.40 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12-gram units) on June 20, 2025, with a completion date of June 23, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $3,993.09 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with an ultimate completion date of June 26, 2025. This non-set-aside, firm fixed-price contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4Y7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,087.14 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the company's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's DLA Troop Support Medical prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Fluticasone Propionate, a corticosteroid inhaler used in respiratory treatment, exemplifies the breadth of pharmaceutical products the contractor routinely delivers through its federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/14/25 |